How much revenue does VIA Pharmaceuticals make?

VIA Pharmaceuticals reported $0 in revenue for fiscal year 2010.

What companies are similar to VIA Pharmaceuticals?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include James E. Wagner Cultivation Corporation (JWCAF), Industry Source Consulting, Inc. (INSO), GeneLink, Inc. (GNLKQ), Item 9 Labs Corp. (INLB).

VIA Pharmaceuticals, Inc. (VIAP) Stock

About VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc., a development stage biotechnology company, focuses on the development of compounds for the treatment of cardiovascular and metabolic diseases. It is developing a pipeline of small molecule drugs that target the underlying causes of cardiovascular and metabolic diseases, including vascular inflammation, high cholesterol, high triglycerides, and insulin sensitization/diabe...

At a glance

VIA Pharmaceuticals reported revenue of $0 for fiscal year 2010, and net income of -$9.60 million.

Figures from company filings; latest fiscal year ended December 31, 2010.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.